| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 19.399 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 32.798 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 10.128 | 104 | 100 | 355 | 21.722 | 0 | 200 | 173 | 0 | 0 |
| Gross Profit/Loss - EUR | -10.128 | -104 | -100 | -355 | 11.076 | 0 | -200 | -173 | 0 | 0 |
| Net Profit/Loss - EUR | -10.128 | -104 | -100 | -355 | 10.092 | 0 | -200 | -173 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Seyo Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.670 | 4.622 | 4.544 | 4.460 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 246.703 | 242.524 | 99.817 | 97.549 | 655 | 642 | 1.237 | 1.240 | 1.236 | 1.230 |
| Inventories | 10.067 | 9.964 | 9.796 | 9.616 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 229.651 | 225.750 | 83.427 | 81.788 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 6.985 | 6.810 | 6.595 | 6.145 | 655 | 642 | 1.237 | 1.240 | 1.236 | 1.230 |
| Shareholders Funds | -9.903 | -9.906 | -9.839 | -10.014 | 272 | 267 | 61 | -112 | -111 | -111 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 261.276 | 257.053 | 114.200 | 112.023 | 382 | 375 | 1.175 | 1.352 | 1.348 | 1.340 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Seyo Pharma Srl